Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted protein degradation via intramolecular bivalent glues
Oliver Hsia, Matthias Hinterndorfer, Angus D. Cowan, et al.
Nature (2024) Vol. 627, Iss. 8002, pp. 204-211
Open Access | Times Cited: 74

Showing 26-50 of 74 citing articles:

Use of Aldehyde–Alkyne–Amine Couplings to Generate Medicinal Chemistry-Relevant Linkers
Andrew McGown, Vesna Vetma, Damien Crépin, et al.
ACS Medicinal Chemistry Letters (2025)
Open Access
Implications of frequent hitter E3 ligases in targeted protein degradation screens
Xiaoyu Zhang, Gabriel M. Simon, Benjamin F. Cravatt
Nature Chemical Biology (2025)
Closed Access
Discovery of DCAF16 Binders for Targeted Protein Degradation
Miguel Campos, Isabella A. Riha, Chenlu Zhang, et al.
ACS Chemical Biology (2025)
Closed Access
A patent review of BRD4 inhibitors (2020-present)
Yanfang Chen, Haonan Zhou, Jiamin Yu, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Multivalent nucleosome scaffolding by bromodomain and extraterminal domain tandem bromodomains
Michael D. Olp, Karina Bursch, Sarah L. Wynia‐Smith, et al.
Journal of Biological Chemistry (2025), pp. 108289-108289
Open Access
Autophagy-Activating Nanoautophagosome-Tethering Compounds for Targeted Protein Degradation Specifically in Tumor Cells
Mengchen Xu, Jiajing Chen, Shuyu Wang, et al.
ACS Macro Letters (2025), pp. 250-257
Closed Access
Computational approaches to aid PROTAC drug discovery
Sohini Chakraborti, Kirsten McAulay
Elsevier eBooks (2025)
Closed Access
Rapid and high-throughput screening of proteolysis targeting chimeras using a dual-reporter system expressing fluorescence protein and luciferase
Shuai Meng, Yuan Meng, Xuena Yang, et al.
BMC Biology (2025) Vol. 23, Iss. 1
Open Access
Resistance to Immunotherapy in Non-small Cell Lung Cancer: Unraveling Causes, Developing Effective Strategies, and Exploring Potential Breakthroughs
Shuang Dong, Xiaoyu Li, Qing Huang, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101215-101215
Closed Access
DET1 dynamics underlie cooperative ubiquitination by CRL4 DET1-COP1 complexes
Abigail E. Burgess, Tarren A. Loughran, Liam S. Turk, et al.
Science Advances (2025) Vol. 11, Iss. 9
Closed Access
The “three body solution”: Structural insights into molecular glues
Aidan C.A. Tomlinson, John E. Knox, Luc Brunsveld, et al.
Current Opinion in Structural Biology (2025) Vol. 91, pp. 103007-103007
Open Access
Recommended Tool Compounds: Thienotriazolodiazepines-Derivatized Chemical Probes to Target BET Bromodomains
Chuhui Huang, Claire L. Harris, Ghizal Siddiqui, et al.
ACS Pharmacology & Translational Science (2025) Vol. 8, Iss. 4, pp. 978-1012
Closed Access
CD36-mediated endocytosis of proteolysis-targeting chimeras
Zheng‐Yu Wang, Bo‐Syong Pan, Rajesh Manne, et al.
Cell (2025)
Open Access
Targeted Protein Degradation: From Basic Science to Therapeutic Applications
R Zhu, Xiaoyu Tang, Heng Zhang
ACS Chemical Biology (2025)
Closed Access
Targeted protein degradation for cancer therapy
Matthias Hinterndorfer, Valentina A. Spiteri, Alessio Ciulli, et al.
Nature reviews. Cancer (2025)
Closed Access
Discovery of CRBN-dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library
Hlib Razumkov, Zixuan Jiang, Kheewoong Baek, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Targeted Protein Degradation (TPD) for Immunotherapy: Understanding Proteolysis Targeting Chimera-Driven Ubiquitin-Proteasome Interactions
Rajamanikkam Kamaraj, Subhrojyoti Ghosh, Souvadra Das, et al.
Bioconjugate Chemistry (2024) Vol. 35, Iss. 8, pp. 1089-1115
Open Access | Times Cited: 3
Interplay of PROTAC Complex Dynamics for Undruggable Targets: Insights into Ternary Complex Behavior and Linker Design
Harish Kumar, M. Elizabeth Sobhia
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 8, pp. 1306-1318
Closed Access | Times Cited: 3
Extrapolating Lessons from Targeted Protein Degradation to Other Proximity-Inducing Drugs
Georg E. Winter
ACS Chemical Biology (2024)
Open Access | Times Cited: 3
New therapies on the horizon: Targeted protein degradation in neuroscience
James A Gregory, Christopher M. Hickey, Juan D. Chavez, et al.
Cell chemical biology (2024) Vol. 31, Iss. 9, pp. 1688-1698
Open Access | Times Cited: 3
Next steps for targeted protein degradation
Mackenzie W. Krone, Craig M. Crews
Cell chemical biology (2024)
Closed Access | Times Cited: 3
CRBN‐PROTACs in Cancer Therapy: From Mechanistic Insights to Clinical Applications
Riya Thapa, Asif Ahmad Bhat, Gaurav Gupta, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 5
Open Access | Times Cited: 3
Inhibitor-induced supercharging of kinase turnover via endogenous proteolytic circuits
Natalie S. Scholes, Martino Bertoni, Arnau Comajuncosa-Creus, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Monovalent Pseudo-Natural Product Degraders Supercharge the Native Degradation of IDO1 by KLHDC3
Elisabeth Hennes, Belén Lucas, Natalie S. Scholes, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Advances in molecular glues: exploring chemical space and design principles for targeted protein degradation
Surendra Kumar, Muthukumaran Venkatachalapathy, Ramesh Sistla, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 11, pp. 104205-104205
Open Access | Times Cited: 2

Scroll to top